Peritoneal dialysis-related peritonitis due to Staphylococcus aureus: a single-center experience over 15 years

Pasqual Barretti1, Taíse M C Moraes, Carlos H Camargo

  • 1Departamento de Clínica Médica, Faculdade de Medicina, UNESP-Universidade Estadual Paulista, Botucatu, São Paulo, Brazil.

Plos One
|February 25, 2012
PubMed

Insights

Staphylococcus aureus peritonitis, a serious complication of peritoneal dialysis (PD), has a declining incidence but remains a significant threat. Host factors like diabetes and bacterial β-hemolysin production predict poor outcomes in PD patients.

Area of Science:

  • Nephrology
  • Infectious Diseases
  • Microbiology

Background:

  • Peritonitis caused by Staphylococcus aureus (S. aureus) is a severe complication of peritoneal dialysis (PD).
  • It is associated with adverse outcomes and high rates of PD failure.
  • Understanding factors influencing S. aureus peritonitis is crucial for improving patient management.

Purpose of the Study:

  • To review S. aureus peritonitis episodes over a 15-year period.
  • To evaluate host and bacterial factors affecting peritonitis outcome.
  • To compare S. aureus peritonitis with coagulase-negative staphylococcus (CoNS) peritonitis.

Main Methods:

  • Retrospective review of 62 S. aureus peritonitis episodes (1996-2010).
  • Analysis of incidence trends using Poisson regression.
  • Evaluation of bacterial virulence factors (biofilm, enzymes, toxins) and oxacillin resistance (MIC, mecA gene).
  • Logistic regression analysis of demographic, clinical, and microbiological factors.

Main Results:

  • S. aureus peritonitis incidence significantly declined from 0.13 to 0.04 episodes/patient/year.
  • Oxacillin resistance was 11.3%; mecA gene presence correlated with fever and abdominal pain.
  • Diabetes mellitus and β-hemolysin production were independent predictors of non-resolution.
  • Patients aged 41-60 had better resolution probability than those >60.
  • S. aureus peritonitis had a trend towards higher mortality (9.7%) compared to CoNS (2.5%).

Conclusions:

  • Despite declining incidence, S. aureus peritonitis remains a serious PD complication with a high death rate.
  • Host factors (age, diabetes) and bacterial β-hemolysin production negatively influence infection outcomes.
  • β-hemolysin production may play a key pathogenic role in PD-related S. aureus peritonitis.

Related Concept Videos

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
Peritoneal Dialysis III: Nursing Management01:25

Peritoneal Dialysis III: Nursing Management

Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...
Peritoneal Dialysis I: Introduction and Procedure01:30

Peritoneal Dialysis I: Introduction and Procedure

Peritoneal dialysis (PD) is a procedure that facilitates the exchange of solutes, waste products, electrolytes, and excess fluid between the blood in the peritoneal capillaries and a dialysis solution introduced into the peritoneal cavity.Principles of Peritoneal Dialysis (PD)Diffusion: Waste products such as urea and electrolytes move from high concentrations in the blood to low concentrations in the dialysate across the peritoneal membrane. This mechanism is driven by the concentration...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis01:30

Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis

Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...